Clinical Trials Directory

Trials / Unknown

UnknownNCT05145803

Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant Setting

Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant Setting: a Study to Understand How Infection Control Practices Can Mitigate Exposure Risks

Status
Unknown
Phase
Study type
Observational
Enrollment
3,300 (estimated)
Sponsor
Colorado School of Public Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The overall aim of this study is to measure how transmission of COVID-19 occurs in communities - including the role of super spreaders and/or identifying conditions that may increase transmission risk, with a focus on congregant situations. In order to identify how presence of symptoms and behavior affects the transmissibility of the virus, the investigators will measure SARS-CoV-2 in exhaled breath of asymptomatic and symptomatic persons using polyvinyl alcohol (PVA) test strips embedded in face masks (Face Mask Sampling- "FMS") - an innovative, non-invasive method for detection of SARS-CoV-2 in exhaled air.

Conditions

Interventions

TypeNameDescription
DEVICEPolyvinylalcohol strip [diagnostic]The investigators will measure SARS-CoV-2 in exhaled breath of asymptomatic and symptomatic persons using PVA test strips embedded in face masks (FMS) - an innovative, non-invasive method for detection of SARS-CoV-2 in exhaled air. Utilizing this approach, the study aims to utilize the test results extracted from the masks to identify risk factors for SARS-CoV-2 transmission and timing of infectious period in exposed people (pre-symptomatic, asymptomatic, and symptomatic).

Timeline

Start date
2021-03-15
Primary completion
2022-03-09
Completion
2022-09-01
First posted
2021-12-06
Last updated
2021-12-20

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05145803. Inclusion in this directory is not an endorsement.